하이로닉 인터내셔널 웹사이트로 이동합니다.
인터내셔널 웹사이트에는 수출용 제품으로 대한민국에서 허가하지 않은 장비 및 서비스 내용을 포함하고 있습니다. 해당 내용은 대한민국의 의료기기 광고 심의, 규제를 받지 않습니다.
It goes to the HIRONIC INTL. website.
The Intrrnation Web Site contains equipment and services that are not authorized by the Republic of Korea These contents are not subject to review and regulation of medical devices in Korea.
하이로닉 US 웹사이트로 이동합니다.
US 웹사이트의 내용은 "FDA"로 부터 허가승인된 품목의 제품 정보에 관한 것으로, 대한민국의 소비자 보호를 위한 국내법 의료기기의 광고 심의, 규제를 받지 않습니다.
It goes to the HIRONIC US website.
The contents of the US web page are about product information of items approved for "FDA". They are not subject to advertising deliberation and regulation of domestic law medical devices for consumer protection in Korea.
하이로닉 EU 웹사이트로 이동합니다.
EU 웹사이트의 내용은 "CE MDD 또는 CE MDR"로 부터 허가승인된 품목의 제품 정보에 관한 것으로, 대한민국의 소비자 보호를 위한 국내법 의료기기의 광고 심의, 규제를 받지 않습니다.
It goes to the HIRONIC EU website.
The contents of the EU(European) web page are about product information of items approved for "CEMDD or CEMDR" in EU countries. They are not subject to advertising deliberation and regulation of domestic law medical devices for consumer protection in Korea.
HIRONIC Co., Ltd. (CEO Jinwoo Lee), a global leader in medical aesthetic technologies, has been awarded the Grand Prize in the Medical Aesthetic Device category at the 2025 Service Customer Satisfaction Awards, hosted by MoneyToday. The ceremony took place at the Korea Press Center in Seoul. This marks the company’s eighth consecutive year receiving this distinguished recognition.
The Service Customer Satisfaction Awards are presented to companies across various industries that deliver exceptional service quality and demonstrate excellence in customer satisfaction. HIRONIC's consistent commitment to customer-centered innovation and advanced product development has once again earned industry-wide acclaim.
HIRONIC is renowned for pioneering integrated treatment technologies in the aesthetic field. Its flagship platform, V-RO ADVANCE (internationally known as New Doublo 2.0™), combines High-Intensity Focused Ultrasound (HIFU), Radio Frequency (RF), and Microneedling into a single, multifunctional system—ushering in a new era of personalized, non-invasive skin rejuvenation.
Expanding its global reach, HIRONIC recently introduced two advanced transdermal delivery solutions: SYNERJET and SYNERJET PRO™. Designed respectively as a cosmetic device for the domestic market and a medical device for international distribution, both systems leverage Micro-Jetting, Electroporation, and Plasma technologies to enable precise and uniform delivery of active ingredients. Notably, SYNERJET PRO™ is engineered to meet stringent medical regulations across multiple markets.
“SYNERJET and SYNERJET PRO™ were developed to align with differing regulatory and clinical needs around the world,” a company spokesperson stated. “We are actively pursuing international certifications and expanding strategic partnerships to enhance the competitive positioning of SYNERJET PRO™ in the global aesthetic medicine landscape.”
Commenting on the award, CEO Jinwoo Lee remarked,
“Receiving this honor for the eighth consecutive year is a profound privilege and responsibility. At HIRONIC, we are committed to sustainable growth built on technological excellence, clinical integrity, and customer trust. We will continue to lead the evolution of aesthetic medicine with innovation that not only satisfies, but truly inspires our customers.”
